279 related articles for article (PubMed ID: 26289583)
41. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension.
Wong GW; Boyda HN; Wright JM
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007451. PubMed ID: 26961574
[TBL] [Abstract][Full Text] [Related]
42. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
Verdecchia P; Gentile G; Angeli F; Reboldi G
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
[TBL] [Abstract][Full Text] [Related]
43. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
Vijan S; Hayward RA
Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
[TBL] [Abstract][Full Text] [Related]
44. Differential effects of angiotensin II receptor blocker and losartan/hydrochlorothiazide combination on central blood pressure and augmentation index.
Metoki H; Obara T; Asayama K; Satoh M; Hosaka M; Elnagar N; Miyawaki Y; Kojima I; Ohkubo T; Imai Y;
Clin Exp Hypertens; 2015; 37(4):294-302. PubMed ID: 25272194
[TBL] [Abstract][Full Text] [Related]
45. [Association of peripheral and central systolic blood pressure with urinary albumin-to-creatinine ratio in a community-based population in Beijing].
Fan FF; Li YX; Jia J; Li HX; Qi LT; Huo Y; Zhang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):220-225. PubMed ID: 28260335
[No Abstract] [Full Text] [Related]
46. Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications: A Systematic Review and Network Meta-analysis.
Wei J; Galaviz KI; Kowalski AJ; Magee MJ; Haw JS; Narayan KMV; Ali MK
JAMA Netw Open; 2020 Feb; 3(2):e1921618. PubMed ID: 32083689
[TBL] [Abstract][Full Text] [Related]
47. Preoperative Renin-Angiotensin System Antagonists Intake and Blood Pressure Responses During Ambulatory Surgical Procedures: A Prospective Cohort Study.
Gurunathan U; Roe A; Milligan C; Hay K; Ravichandran G; Chawla G
Anesth Analg; 2024 Apr; 138(4):763-774. PubMed ID: 38236756
[TBL] [Abstract][Full Text] [Related]
48. [Comparative Efficacy of the Influence of Fixed Combinations of Antihypertensive Drugs That Block the Renin-Angiotensin-Aldosterone System, With Thiazide Diuretics on the Parameters of Ambulatory Blood Pressure Monitoring].
Ostroumova OD; Garelik IA
Kardiologiia; 2016 Dec; 56(12):20-26. PubMed ID: 28290800
[TBL] [Abstract][Full Text] [Related]
49. Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis.
Seleme VB; Marques GL; Mendes AEM; Rotta I; Pereira M; Júnior EL; da Cunha CLP
Am J Cardiovasc Drugs; 2021 Mar; 21(2):165-180. PubMed ID: 32710438
[TBL] [Abstract][Full Text] [Related]
50. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure.
Naci H; Salcher-Konrad M; Dias S; Blum MR; Sahoo SA; Nunan D; Ioannidis JPA
Br J Sports Med; 2019 Jul; 53(14):859-869. PubMed ID: 30563873
[TBL] [Abstract][Full Text] [Related]
51. Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.
Mancia G; Cannon CP; Tikkanen I; Zeller C; Ley L; Woerle HJ; Broedl UC; Johansen OE
Hypertension; 2016 Dec; 68(6):1355-1364. PubMed ID: 27977392
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.
Staessen JA; Wang JG; Thijs L
J Hypertens; 2003 Jun; 21(6):1055-76. PubMed ID: 12777939
[TBL] [Abstract][Full Text] [Related]
53. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
[TBL] [Abstract][Full Text] [Related]
54. Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research.
Loader J; Taylor FC; Lampa E; Sundström J
J Am Heart Assoc; 2022 Jun; 11(11):e025289. PubMed ID: 35624081
[TBL] [Abstract][Full Text] [Related]
55. Update on the management of hypertension: recent clinical trials and the JNC 7.
Moser M
J Clin Hypertens (Greenwich); 2004 Oct; 6(10 Suppl 2):4-13. PubMed ID: 15470293
[TBL] [Abstract][Full Text] [Related]
56. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
Antza C; Stabouli S; Kotsis V
Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
[TBL] [Abstract][Full Text] [Related]
57. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
Ku E; McCulloch CE; Vittinghoff E; Lin F; Johansen KL
J Am Heart Assoc; 2018 Oct; 7(19):e009992. PubMed ID: 30371331
[TBL] [Abstract][Full Text] [Related]
58. Hypertension control in the elderly.
Neutel JM; Gilderman LI
J Clin Hypertens (Greenwich); 2008 Jan; 10(1 Suppl 1):33-9. PubMed ID: 18174782
[TBL] [Abstract][Full Text] [Related]
59. Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.
Salvador GL; Marmentini VM; Cosmo WR; Junior EL
Eur J Prev Cardiol; 2017 Dec; 24(18):1914-1924. PubMed ID: 28862020
[TBL] [Abstract][Full Text] [Related]
60. Evening versus morning dosing regimen drug therapy for hypertension.
Wu C; Zhao P; Xu P; Wan C; Singh S; Varthya SB; Luo SH
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD004184. PubMed ID: 38353289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
